Pfizer's Upjohn strikes generic Viagra deal with telehealth provider Roman

viagra
Greenstone will exclusively supply generic Viagra to Roman, an all-digital telehealth provider. (Pfizer)

Despite positive signs that Pfizer's Mylan-partnered spinoff of generics business Upjohn could be a win for all parties, uncertainty has clouded the new company's future. Now, at least one thing will be certain: It'll have a buyer for generic Viagra––and an unconventional one at that. 

Greenstone, the U.S. subsidiary of Pfizer's Upjohn, has reached an exclusive supply deal with telehealth provider Roman for access to Pfizer's FDA-approved generic of erectile dysfunction med Viagra (sildenafil citrate). 

Under the agreement, Roman will source the generic exclusively through Greenstone with the drug being manufactured in the same European facilities as branded Viagra at no extra cost to Roman subscribers, Pfizer said in a release. Roman is a subsidiary of telehealth provider Ro specializing in men's health, Pfizer said.

Pfizer's decision to provide generic Viagra exclusively to Roman comes as the drugmaker prepares for its much-ballyhooed Upjohn spinoff with generics giant Mylan. 

RELATED: Pfizer may look messy post-Upjohn spinoff, but better days could be ahead: analyst

Suggested Articles

Lupin Pharmaceuticals has shut down an Indian generics plant after 18 workers tested positive for COVID-19, Reuters reported.

Merck KGaA could see billions of dollars in revenue opportunity as it assists certain players with their COVID-19 scale-up, an analyst says. 

The FDA approved Johnson & Johnson's Tremfya as the first IL-23 inhibitor to treat psoriatic arthritis, joining a suite of immunology blockbusters.